The feed anticoccidials market size is projected to reach US$ 1.63 billion by 2031 from US$ 1.25 billion in 2023. The market is expected to register a CAGR of 3.3% during 2023–2031. The rising adoption of bio shuttle programs is likely to continue as a key trend in the market. The bio shuttle program involves strategically using advanced technologies and practices to prevent coccidiosis and enhance bird health and performance. The program can improve feed conversions and weight gain while assisting in managing intestinal injuries.
The growth in livestock production is likely to create a demand for feed anticoccidials to fight against diseases such as coccidiosis. Livestock farmers are also concerned about the health of livestock. Thus, they are adopting various strategies to fight against diseases and investing in feed antibiotics such as anticoccidials. Phibro Animal Health Corp, Kemin Industries Inc., Elanco Animal Health Inc., Zoetis Inc., and Huvepharma EOOD are among the major feed anticoccidials manufacturers operating in the market. Market players are investing in research & development to launch more efficient products with improved benefits to attract a large number of consumers.
Feed anticoccidials are feed additives used to prevent intestinal diseases such as coccidiosis among livestock animals. It is considered an antibiotic in animal feed. There are three types of feed anticoccidials available i.e., ionophores, chemical anticoccidials, and chemical-ionophores. The prevalence of coccidiosis is increasing in poultry birds, equines, and ruminants. Thus, livestock farmers and feed manufacturers are incorporating anticoccidials in animal feed that can further reduce the impact of intentional disease caused by parasites. Moreover, the surging livestock population across the globe with increasing meat and dairy consumption creates a huge demand for feed anticoccidials as a feed additive.
Coccidiosis directly infects animals and reduces their performance; it results in large economic losses. Owing to its direct impact on flock appearance and intestinal health, it is a major global concern in the poultry industry. The EW Nutrition Technical Team reports that coccidial illness costs the poultry sector more than US$ 14 billion a year and is a serious intestinal problem. Owing to damage to the intestinal cells, the disease results in decreased body weights, increased feed conversion rates, abnormalities in skin color, irregular flock sizes, and ultimately, death. According to DSM, across the world, yearly losses were estimated at more than US$ 3 billion due to coccidiosis in chickens and other avian species. Thus, coccidiosis prevention is becoming essential for producers, veterinary associations, and regulatory authorities of various countries.
According to the World Health Organization (WHO), the usage of antibiotics such as an anticoccidial in animal feed as an additive can treat infections. There is a surge in the use of anticoccidials in feed by animal feed manufacturers to fight against infection in animals, overcome losses, and improve farm profitability. Thus, the rising prevalence of coccidiosis fuels the feed anticoccidial market growth.
Non-ionophores are compounds produced by chemical synthesis; thus, they fall under the category of chemical anticoccidials. They destroy coccidia by cidal activity or suppress coccidia by static activity. They have no known antibacterial activity; hence, they are not considered as an antibiotic. Non-ionophores are products containing nicarbazin, zoalene, amprolium, clopidol, decoquinate, robenidine and diclazuril. EW Nutrition—an agribusiness company that creates solutions that bring reliable benefits with reduced need for antibiotics, especially in feed—has developed non-ionophores for animal feed. Owing to all these factors, livestock farmers concerned about using antibiotics in animal feed can opt for non-ionophore anticoccidials. Therefore, the introduction of non-ionophore in animal feed is expected to offer lucrative opportunities for the feed anticoccidials market during the forecast period.
Key segments that contributed to the derivation of the feed anticoccidials market analysis are type, form, and livestock.
The geographic scope of the feed anticoccidials market report is mainly divided into five regions—North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. Asia Pacific held the largest market share in 2023, whereas the market in South & Central America is expected to register the highest CAGR during the forecast period.
The feed anticoccidials market in South & Central America is driven by the growing livestock industry and rising producer awareness about animal health. Brazil, Argentina, and Mexico are among the major players in the global meat export market, majorly in the beef and poultry sectors. The growing livestock sector increases the use of effective disease management solutions, including anticoccidials, to protect animal health and boost productivity. Anticoccidial drugs are crucial in controlling coccidiosis, a major concern for poultry and other livestock, which can significantly impact farm profitability by reducing productivity. The adoption of these practices is gaining momentum in health and nutrition management, aiming to prevent coccidiosis, enhance animal health, and improve feed efficiency. Hence, the region has experienced a significant increase in the use of anticoccidial feed additives.
South & Central America is experiencing a growing trend toward sustainable and environmentally friendly livestock production practices. Moreover, the region's regulatory frameworks are changing to ensure food safety and animal welfare. The demand for anticoccidial solutions is driven by the growing consumption of animal protein and rising global market exports. This factor, along with enhanced livestock health standards and productivity, would present significant opportunities for the feed anticoccidials market in the region during the forecast period.
The regional trends and factors influencing the Feed Anticoccidials Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Feed Anticoccidials Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 1.25 Billion |
| Market Size by 2031 | US$ 1.63 Billion |
| Global CAGR (2023 - 2031) | 3.3% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Feed Anticoccidials Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Feed Anticoccidials Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The feed anticoccidials market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few key recent developments in the feed anticoccidials market are listed below:
The "Feed Anticoccidials Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
Adoption of bio shuttle program for managing coccidiosis is likely to emerge as a key trend in the market in the future.
Asia Pacific accounted for the largest share of the market in 2023.
The increasing production of livestock and the rising prevalence of coccidiosis contribute to the growth of the market.
The market size is projected to reach US$ 1.63 million by 2031.
Phibro Animal Health Corp, Kemin Industries Inc., Elanco Animal Health Inc., Zoetis Inc., Huvepharma EOOD, Innovista Feeding Solutions Pvt Ltd, Impextraco NV, Virbac SA, International Animal Health Products Pty Ltd, and Zamira Australia Ltd are a few of the key players operating in the market.